 27. Serious illness or concomitant non-oncological disease such as neurologic, psychiatric, infectious disease or active ulcers gastro-intestinal tract, skin or laboratory abnormality that may increase the risk associated with study participation or study drug administration and in the judgment of the investigator would make the patient inappropriate for entry into the study. 